PETS Stock Overview
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
PetMed Express, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.02 |
| 52 Week High | US$16.18 |
| 52 Week Low | US$3.95 |
| Beta | 0.70 |
| 1 Month Change | -16.08% |
| 3 Month Change | -40.00% |
| 1 Year Change | -73.85% |
| 3 Year Change | -86.34% |
| 5 Year Change | -81.47% |
| Change since IPO | 221.60% |
Recent News & Updates
Recent updates
A Look At The Fair Value Of PetMed Express, Inc. (NASDAQ:PETS)
Oct 09
PetMed Express (NASDAQ:PETS) Is Paying Out A Dividend Of $0.30
Aug 07The Returns On Capital At PetMed Express (NASDAQ:PETS) Don't Inspire Confidence
Mar 23PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Feb 10PetMed Express (NASDAQ:PETS) Will Pay A Dividend Of $0.30
Nov 11PetMed Express Puts Are Compelling
Aug 25PetMed Express CFO to leave post today, by remain with company over transition period
Aug 02PetMed Express' (NASDAQ:PETS) Dividend Will Be $0.30
Jul 29PetMed Express FQ1 2023 Earnings Preview
Jul 24PetMeds becomes exclusive U.S. fulfillment partner for Vetster, telemedicine platform
Jul 15Returns On Capital At PetMed Express (NASDAQ:PETS) Paint A Concerning Picture
Jul 04PetMed Express: 'AutoShip & Save' Program Key Driver Of Growth
May 26PetMed Express (NASDAQ:PETS) Has Affirmed Its Dividend Of US$0.30
May 13Silver Ring Value Partners - PetMed Express: Squeezed Out Of Obtaining New Customers
Feb 22PetMed Express: Avoid For Now
Jan 17PetMed Express Needs A White Knight
Sep 26PetMed Express (NASDAQ:PETS) Is Increasing Its Dividend To US$0.30
Jul 29PetMed Express: Top Dog For Pet Dividends - Pet Industry Review
Jul 11PetMed Express: A Safe Dividend, But Lacks A Margin Of Safety
Jun 15Estimating The Intrinsic Value Of PetMed Express, Inc. (NASDAQ:PETS)
Jun 11PetMed reaches highest level since January as meme stocks rally
Jun 02PetMed Express EPS misses by $0.06, misses on revenue
May 03Shareholder Returns
| PETS | US Specialty Retail | US Market | |
|---|---|---|---|
| 7D | -2.2% | 3.1% | 2.9% |
| 1Y | -73.8% | 11.3% | 22.2% |
Return vs Industry: PETS underperformed the US Specialty Retail industry which returned 11.4% over the past year.
Return vs Market: PETS underperformed the US Market which returned 22.2% over the past year.
Price Volatility
| PETS volatility | |
|---|---|
| PETS Average Weekly Movement | 4.9% |
| Specialty Retail Industry Average Movement | 7.0% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: PETS's share price has been volatile over the past 3 months.
Volatility Over Time: PETS's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 302 | Matt Hulett | www.1800petmeds.com |
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.
PetMed Express, Inc. Fundamentals Summary
| PETS fundamental statistics | |
|---|---|
| Market cap | US$81.99m |
| Earnings (TTM) | -US$2.66m |
| Revenue (TTM) | US$276.97m |
0.3x
P/S Ratio-30.8x
P/E RatioIs PETS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PETS income statement (TTM) | |
|---|---|
| Revenue | US$276.97m |
| Cost of Revenue | US$199.11m |
| Gross Profit | US$77.85m |
| Other Expenses | US$80.52m |
| Earnings | -US$2.66m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.13 |
| Gross Margin | 28.11% |
| Net Profit Margin | -0.96% |
| Debt/Equity Ratio | 0% |
How did PETS perform over the long term?
See historical performance and comparison